PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib

计划入组 93 人 · 首次发布于 2015 年 3 月 17 日

Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease

计划入组 20 人 · 首次发布于 2023 年 8 月 2 日

Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors

计划入组 33 人 · 首次发布于 2011 年 4 月 28 日

antiviral kinase

Rx-kinase

kinase inhibitor (Pfizer)

Exelixis, Inc.

United States

Inhibikase Therapeutics

United States

Regeneron Pharmaceuticals

United States

First European Patient Receives Breakthrough Treatment for Ultra-Rare APDS Immune Disorder

EMA Grants Conditional Approval for Vijoice, First Treatment for Rare PIK3CA-Related Overgrowth Disorders

Capivasertib Shows Promise in ER+/HER2- Metastatic Breast Cancer with PIK3CA Mutations